HSP27 may suppress apoptosis in oral cancer and facilitate tumor immune rejection by modulating the β-catenin/MMP-3 signaling cascade and by the upregulation of NF-ĸB signaling pathways [27,31,33]. This evidence concerns the gene HSPB1 and lip and oral cavity carcinoma.